{"id":785,"date":"2026-08-13T10:31:24","date_gmt":"2026-08-13T08:31:24","guid":{"rendered":"https:\/\/staging.diabetes.si\/2026\/08\/13\/novi-lijek-s-visestrukim-ucincima\/"},"modified":"2026-09-02T16:03:30","modified_gmt":"2026-09-02T14:03:30","slug":"novi-lijek-s-visestrukim-ucincima","status":"publish","type":"post","link":"https:\/\/diabetes.si\/hr\/2026\/08\/13\/novi-lijek-s-visestrukim-ucincima\/","title":{"rendered":"Novi lijek s vi\u0161estrukim u\u010dincima?"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Novi lijek za dijabetes tako\u0111er utje\u010de na kardiovaskularne ishode<\/strong><\/p>\n\n<p class=\"wp-block-paragraph\">Tekst: Matej Lov\u0161in, foto: Vecteezy<\/p>\n\n<p class=\"wp-block-paragraph\">Eksperimentalni lijek IC7Fc, izvorno razvijen za upravljanje dijabetesom tipa 2 i pretilo\u0161\u0107u, tako\u0111er pokazuje obe\u0107avaju\u0107e u\u010dinke u sprje\u010davanju kardiovaskularnih bolesti. Nedavna predklini\u010dka studija otkriva da lijek sni\u017eava kolesterol, masno\u0107e u krvi i upale, a istovremeno inhibira stvaranje masnih plakova u arterijama &#8211; klju\u010dnih \u010dimbenika sr\u010danog i mo\u017edanog udara.<\/p>\n\n<p class=\"wp-block-paragraph\">Me\u0111unarodni istra\u017eiva\u010dki tim predvo\u0111en Medicinskim centrom Sveu\u010dili\u0161ta u Leidenu objavio je rezultate u \u010dasopisu <em>Science Advances<\/em> . U eksperimentima na mi\u0161evima genetski predisponiranima za visoki kolesterol, IC7Fc je zna\u010dajno snizio razinu triglicerida i kolesterola te smanjio aterosklerozu, postupno &#8220;za\u010depljenje&#8221; arterija.<\/p>\n\n<p class=\"wp-block-paragraph\">Va\u017ean nalaz studije je da su se ovi za\u0161titni u\u010dinci pojavili \u010dak i bez utjecaja na tjelesnu te\u017einu. Iako je lijek u prethodnim studijama smanjio apetit i tjelesnu te\u017einu kod pretilih mi\u0161eva, nije imao te u\u010dinke kod mr\u0161avih mi\u0161eva, ali je i dalje bio uspje\u0161an u za\u0161titi krvnih \u017eila. To sugerira da bi IC7Fc mogao koristiti i osobama koje nemaju prekomjernu te\u017einu, a imaju pove\u0107an rizik od kardiovaskularnih bolesti. Kako isti\u010de voditelj studije, profesor Mark Febbraio sa Sveu\u010dili\u0161ta Monash, kardiovaskularne bolesti ostaju vode\u0107i uzrok smrti u svijetu, unato\u010d postoje\u0107im terapijama. Nova otkri\u0107a stoga predstavljaju va\u017ean korak prema razvoju lijeka koji bi istovremeno utjecao na metaboli\u010dke i kardiovaskularne \u010dimbenike rizika. Me\u0111utim, prije mogu\u0107e upotrebe na ljudima bit \u0107e potrebna dodatna klini\u010dka istra\u017eivanja.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Novi lijek za dijabetes tako\u0111er utje\u010de na kardiovaskularne ishode Tekst: Matej Lov\u0161in, foto: Vecteezy Eksperimentalni lijek IC7Fc, izvorno razvijen za upravljanje dijabetesom tipa 2 i pretilo\u0161\u0107u, tako\u0111er pokazuje obe\u0107avaju\u0107e u\u010dinke u sprje\u010davanju kardiovaskularnih bolesti. Nedavna predklini\u010dka studija otkriva da lijek sni\u017eava kolesterol, masno\u0107e u krvi i upale, a istovremeno inhibira stvaranje masnih plakova u arterijama [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":786,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[93,62],"tags":[],"class_list":["post-785","post","type-post","status-publish","format-standard","has-post-thumbnail","category-lijecenje","category-vijesti"],"_links":{"self":[{"href":"https:\/\/diabetes.si\/hr\/wp-json\/wp\/v2\/posts\/785","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/diabetes.si\/hr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/diabetes.si\/hr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/diabetes.si\/hr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/diabetes.si\/hr\/wp-json\/wp\/v2\/comments?post=785"}],"version-history":[{"count":1,"href":"https:\/\/diabetes.si\/hr\/wp-json\/wp\/v2\/posts\/785\/revisions"}],"predecessor-version":[{"id":787,"href":"https:\/\/diabetes.si\/hr\/wp-json\/wp\/v2\/posts\/785\/revisions\/787"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/diabetes.si\/hr\/wp-json\/wp\/v2\/media\/786"}],"wp:attachment":[{"href":"https:\/\/diabetes.si\/hr\/wp-json\/wp\/v2\/media?parent=785"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/diabetes.si\/hr\/wp-json\/wp\/v2\/categories?post=785"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/diabetes.si\/hr\/wp-json\/wp\/v2\/tags?post=785"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}